Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 192 de 371.

Grafa

Artiva Biotherapeutics secures FDA alignment for Phase 3 RA trial after strong Phase 2a results

Artiva Biotherapeutics (NASDAQ:ARTV) has reached a pivotal regulatory milestone, securing FDA alignment for a single Phase 3 registrational trial of its lead candidate, AlloNK, following positive initial data in refractory rheumatoid arthritis (RA).

Leia mais: Artiva Biotherapeutics secures FDA alignment for Phase 3 RA trial after strong Phase 2a results
Grafa

Creative Media & Community Trust reports multifamily growth amid strategic restructuring

Creative Media & Community Trust (NASDAQ:CMCT) reported operating results for the first quarter of 2026, characterized by a dual focus on operational improvement in residential assets and a sweeping overhaul of its capital structure.

Leia mais: Creative Media & Community Trust reports multifamily growth amid strategic restructuring
Grafa

Century Casinos hits all-time record Q1 revenue as operational turnaround accelerates

Century Casinos (NASDAQ:CNTY) delivered a record-breaking performance for the opening quarter of 2026, signaling that its recent capital investments and geographic diversification are beginning to yield higher operational efficiency.

Leia mais: Century Casinos hits all-time record Q1 revenue as operational turnaround accelerates